Works matching IS 02724391 AND DT 2024 AND VI 85 AND IP 3

Results: 16

Identification of ROS and KEAP1‐related genes and verified targets of α‐hederin induce cell death for CRC.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22200

By:

Wang, Gang;
Zhu, Zhi‐Min;
Wang, Kun

Publication type:

Article

Noscapine modulates hypoxia‐induced angiogenesis and hemodynamics: Insights from a zebrafish model investigation.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22195

By:

Nathan, Jhansi;
Shameera, Rabiathul;
Sivakumar, Kaniha;
Rajendran, Soundarya;
Perumal, Elumalai

Publication type:

Article

Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)‐sensitive and ‐resistant strains.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22194

By:

Islam, Arshad;
do Prado, Bruno Rodrigues;
Dittz, Dalton;
Rodrigues, Bernardo Lages;
Silva, Sydnei Magno da;
do Monte‐Neto, Rubens L.;
Shabeer, Muhammad;
Frézard, Frédéric;
Demicheli, Cynthia

Publication type:

Article

Design, synthesis, and biological evaluation of dinaciclib and CAN508 hybrids as CDK inhibitors.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22193

By:

Odeh, Dana M.;
Allam, Heba Abdelrasheed;
Baselious, Fady;
Mahmoud, Walaa R.;
Odeh, Mohanad M.;
Ibrahim, Hany S.;
Abdel‐Aziz, Hatem A.;
Mohammed, Eman R.

Publication type:

Article

Anti‐NSCLC role of SCN4B by negative regulation of the cGMP‐PKG pathway: Integrated utilization of bioinformatics analysis and in vitro assay validation.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22192

By:

Yang, Xiujun;
Liu, Qun;
Li, Gang

Publication type:

Article

Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In‐vitro permeation and preclinical evaluation.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22191

By:

Bule, Prajakta;
Kadkanje, Prashant;
Kshirsagar, Ravikiran;
Puppala, Eswara Rao;
Naidu, Vegi Ganga Modi;
Chella, Naveen

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22190
Publication type:: Article

Chitosan‐coated nanoparticles in innovative cancer bio‐medicine.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22189

By:

Rezaei, Niloufar;
Zarkesh, Ibrahim;
Fotouhi, Alireza;
Alikhani, Hani Keshavarz;
Hassan, Moustapha;
Vosough, Massoud

Publication type:

Article

Comparisons of successful and failed Phase III trials of drugs and biologicals tested for mitigation of oral mucositis in patients being treated with radiotherapy with or without concomitant chemotherapy for cancers of the head and neck.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22188

By:

Liang, Lang;
Sonis, Stephen T.

Publication type:

Article

Single and multiple inhibitors of the biosynthesis of 5‐, 12‐, 15‐lipoxygenase products derived from cinnamyl‐3,4‐dihydroxy‐α‐cyanocinnamate: Synthesis and structure–activity relationship.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22181

By:

Touaibia, Mohamed;
Chiasson, Audrey Isabel;
Robichaud, Samuel;
Doiron, Jérémie A.;
Hébert, Mathieu P. A.;
Surette, Marc E.

Publication type:

Article

Upregulation of FGF9 and NOVA1 in cancer‐associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22185

By:

Zhang, Bo;
Liu, Yang;
Yu, Jinsong;
Lin, Xi

Publication type:

Article

In vitro and in silico investigation of FDA‐approved drugs to be repurposed against Alzheimer's disease.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22184

By:

Akkaya, Didem;
Seyhan, Gökçe;
Sari, Suat;
Barut, Burak

Publication type:

Article

Synthesis and investigation of the cholinesterase inhibitory and antioxidant capacities of some novel N'‐(quinolin‐4‐ylmethylene)propanehydrazides against Alzheimer's disease.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22183

By:

Kilic, Burcu;
Dogruer, Deniz S.

Publication type:

Article

Synthesis, docking study, and antitumor evaluation of benzamides and oxadiazole derivatives of 3‐phenoxybenzoic acid as VEGFR‐2 inhibitors.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22186

By:

Heriz, Mohammad H.;
Mahmood, Ammar A. R.;
Yasin, Salem R.;
Saleh, Khaled M.;
AlSakhen, Mai F.;
Kanaan, Sana I.;
Himsawi, Nisreen;
Saleh, Abdulrahman M.;
Tahtamouni, Lubna H.

Publication type:

Article

A review of natural products and small‐molecule therapeutics acting on central nervous system malignancies: Approaches for drug development, targeting pathways, clinical trials, and challenges.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22180

By:

Pasdaran, Ardalan;
Grice, Irwin Darren;
Hamedi, Azadeh

Publication type:

Article

Design, synthesis, and bioactivity evaluation of clindamycin derivatives against multidrug‐resistant bacterial strains.

Published in:

Drug Development Research, 2024, v. 85, n. 3, p. 1, doi. 10.1002/ddr.22182

By:

Jia, Yiduo;
Zhang, Yinmeng;
Zhu, Hong;
Wang, Ming

Publication type:

Article